Physician profile
Adrian Dafcik
NPI 1043221179
$631.15
in general payments reported to CMS, 2019-2025
9 companies · $15.48 in 2025
The $15.48 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $125 · 2022: $122 · 2023: $193 · 2024: $27.83 · 2025: $15.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $236.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $193.57 | 2020-2023 | |
| Glaxosmithkline, LLC. | $125.00 | 2023 | Arexvy |
| Janssen Pharmaceuticals, INC | $125.00 | 2019 | |
| Sunovion Pharmaceuticals INC. | $58.09 | 2022 | |
| Sumitomo Pharma America, INC. | $49.75 | 2023 | Gemtesa |
| Abbvie INC. | $27.80 | 2022-2024 | |
| Novo Nordisk INC | $22.48 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.48 | 2025 | Jardiance |
| Ardelyx, INC. | $13.98 | 2024 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrian Dafcik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.